Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital Construction
Max Healthcare approved FY26 audited standalone and consolidated results ending March 31, 2026. The board recommended a final dividend of ₹2 per equity share. Approval was given for the construction of Phase-I of a new hospital in Lucknow and the shifting of the registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a Non-Executive Director.
The approval of financial results, dividend recommendation, and major capital expenditure for a new hospital construction are significant events that can impact investor sentiment and the company's future growth prospects.
The announcement details positive corporate actions including the approval of financial results, recommendation of a dividend, and significant capital expenditure for a new hospital, all contributing to a positive outlook.
Max Healthcare Institute Limited announced the approval of its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The board of directors, based on the recommendation of the Audit Committee, approved these results, on which S.R. Batliboi & Co. LLP, the statutory auditors, issued an unmodified report.
The company also recommended a final dividend of ₹2 per equity share, representing 20% of the face value of ₹10. This dividend is subject to the approval of the shareholders and will be paid/dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting (AGM).
Further, the board approved the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Accountants for the financial year 2026-27. In a significant strategic move, the company approved the construction of Phase-I of the Max Super Specialty Hospital in Lucknow, which will accommodate approximately 712 beds.
Additionally, the board approved the shifting of the company's registered office from Maharashtra to Haryana, subject to member and regulatory approvals. The re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, was also approved, pending shareholder approval at the AGM.
The board also considered and approved the re-classification request from Radiant Life Care Hospital Foundation from ‘Promoter Group’ to ‘Public’ category, pending stock exchange approvals.
The board meeting commenced at 12:07 pm IST and concluded at 3:44 pm IST on May 21, 2026.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.